Global Genetically Engineered Vaccines Market Growth 2026-2032
The global Genetically Engineered Vaccines market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Genetically Engineered Vaccines Industry Forecast? looks at past sales and reviews total world Genetically Engineered Vaccines sales in 2025, providing a comprehensive analysis by region and market sector of projected Genetically Engineered Vaccines sales for 2026 through 2032. With Genetically Engineered Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genetically Engineered Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Genetically Engineered Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genetically Engineered Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Genetically Engineered Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genetically Engineered Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genetically Engineered Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Genetically Engineered Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Genetically Engineered Vaccines Industry Forecast? looks at past sales and reviews total world Genetically Engineered Vaccines sales in 2025, providing a comprehensive analysis by region and market sector of projected Genetically Engineered Vaccines sales for 2026 through 2032. With Genetically Engineered Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genetically Engineered Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Genetically Engineered Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genetically Engineered Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Genetically Engineered Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genetically Engineered Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genetically Engineered Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Genetically Engineered Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Genetic Recombinant Vaccine
- Recombinant Subunit Vaccines
- Genetic Vaccine
- Veterinary Use
- Human Use
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Merck
- GSK
- Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
- Walvax Biotechnology Co., Ltd.
- Bharat Biotech
- Sanofi
- Zoties
- Elanco
- Boehringer Ingelheim
- Indian Immunologicals
- China Animal Husbandry Industry Co.,Ltd.
- Yebio Bioengineering Co., Ltd Of Qingdao
- Jinyu Bio-technology Co.,ltd.
- HVRI
- Ringpu Biology
- Kyoto Biken Laboratories
- FATRO
- Ceva Sant? Animale
- Pulike Biological Engineering,Inc.
- Wuhan Hvsen Biotechnology CO.,LTD
- Jinhe Biotechnology Co., Ltd.
- Shanghai Shen Lian Biomedical Corporation
- Qingdao Vland Biotech INC.
- What is the 10-year outlook for the global Genetically Engineered Vaccines market?
- What factors are driving Genetically Engineered Vaccines market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Genetically Engineered Vaccines market opportunities vary by end market size?
- How does Genetically Engineered Vaccines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Genetically Engineered Vaccines Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Genetically Engineered Vaccines by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Genetically Engineered Vaccines by Country/Region, 2021, 2025 & 2032
2.2 Genetically Engineered Vaccines Segment by Type
2.2.1 Genetic Recombinant Vaccine
2.2.2 Recombinant Subunit Vaccines
2.2.3 Genetic Vaccine
2.2.4 Genetically Engineered Vaccines Sales by Type
2.2.4.1 Global Genetically Engineered Vaccines Sales Market Share by Type (2021-2026)
2.2.4.2 Global Genetically Engineered Vaccines Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Genetically Engineered Vaccines Sale Price by Type (2021-2026)
2.3 Genetically Engineered Vaccines Segment by Application
2.3.1 Veterinary Use
2.3.2 Human Use
2.3.3 Genetically Engineered Vaccines Sales by Application
2.3.3.1 Global Genetically Engineered Vaccines Sale Market Share by Application (2021-2026)
2.3.3.2 Global Genetically Engineered Vaccines Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Genetically Engineered Vaccines Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Genetically Engineered Vaccines Breakdown Data by Company
3.1.1 Global Genetically Engineered Vaccines Annual Sales by Company (2021-2026)
3.1.2 Global Genetically Engineered Vaccines Sales Market Share by Company (2021-2026)
3.2 Global Genetically Engineered Vaccines Annual Revenue by Company (2021-2026)
3.2.1 Global Genetically Engineered Vaccines Revenue by Company (2021-2026)
3.2.2 Global Genetically Engineered Vaccines Revenue Market Share by Company (2021-2026)
3.3 Global Genetically Engineered Vaccines Sale Price by Company
3.4 Key Manufacturers Genetically Engineered Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Genetically Engineered Vaccines Product Location Distribution
3.4.2 Players Genetically Engineered Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GENETICALLY ENGINEERED VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Genetically Engineered Vaccines Market Size by Geographic Region (2021-2026)
4.1.1 Global Genetically Engineered Vaccines Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Genetically Engineered Vaccines Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Genetically Engineered Vaccines Market Size by Country/Region (2021-2026)
4.2.1 Global Genetically Engineered Vaccines Annual Sales by Country/Region (2021-2026)
4.2.2 Global Genetically Engineered Vaccines Annual Revenue by Country/Region (2021-2026)
4.3 Americas Genetically Engineered Vaccines Sales Growth
4.4 APAC Genetically Engineered Vaccines Sales Growth
4.5 Europe Genetically Engineered Vaccines Sales Growth
4.6 Middle East & Africa Genetically Engineered Vaccines Sales Growth
5 AMERICAS
5.1 Americas Genetically Engineered Vaccines Sales by Country
5.1.1 Americas Genetically Engineered Vaccines Sales by Country (2021-2026)
5.1.2 Americas Genetically Engineered Vaccines Revenue by Country (2021-2026)
5.2 Americas Genetically Engineered Vaccines Sales by Type (2021-2026)
5.3 Americas Genetically Engineered Vaccines Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genetically Engineered Vaccines Sales by Region
6.1.1 APAC Genetically Engineered Vaccines Sales by Region (2021-2026)
6.1.2 APAC Genetically Engineered Vaccines Revenue by Region (2021-2026)
6.2 APAC Genetically Engineered Vaccines Sales by Type (2021-2026)
6.3 APAC Genetically Engineered Vaccines Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Genetically Engineered Vaccines by Country
7.1.1 Europe Genetically Engineered Vaccines Sales by Country (2021-2026)
7.1.2 Europe Genetically Engineered Vaccines Revenue by Country (2021-2026)
7.2 Europe Genetically Engineered Vaccines Sales by Type (2021-2026)
7.3 Europe Genetically Engineered Vaccines Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Genetically Engineered Vaccines by Country
8.1.1 Middle East & Africa Genetically Engineered Vaccines Sales by Country (2021-2026)
8.1.2 Middle East & Africa Genetically Engineered Vaccines Revenue by Country (2021-2026)
8.2 Middle East & Africa Genetically Engineered Vaccines Sales by Type (2021-2026)
8.3 Middle East & Africa Genetically Engineered Vaccines Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Genetically Engineered Vaccines
10.3 Manufacturing Process Analysis of Genetically Engineered Vaccines
10.4 Industry Chain Structure of Genetically Engineered Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Genetically Engineered Vaccines Distributors
11.3 Genetically Engineered Vaccines Customer
12 WORLD FORECAST REVIEW FOR GENETICALLY ENGINEERED VACCINES BY GEOGRAPHIC REGION
12.1 Global Genetically Engineered Vaccines Market Size Forecast by Region
12.1.1 Global Genetically Engineered Vaccines Forecast by Region (2027-2032)
12.1.2 Global Genetically Engineered Vaccines Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Genetically Engineered Vaccines Forecast by Type (2027-2032)
12.7 Global Genetically Engineered Vaccines Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Genetically Engineered Vaccines Product Portfolios and Specifications
13.1.3 Pfizer Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Genetically Engineered Vaccines Product Portfolios and Specifications
13.2.3 Merck Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Genetically Engineered Vaccines Product Portfolios and Specifications
13.3.3 GSK Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
13.4.1 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Company Information
13.4.2 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Product Portfolios and Specifications
13.4.3 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Main Business Overview
13.4.5 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Latest Developments
13.5 Walvax Biotechnology Co., Ltd.
13.5.1 Walvax Biotechnology Co., Ltd. Company Information
13.5.2 Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
13.5.3 Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Walvax Biotechnology Co., Ltd. Main Business Overview
13.5.5 Walvax Biotechnology Co., Ltd. Latest Developments
13.6 Bharat Biotech
13.6.1 Bharat Biotech Company Information
13.6.2 Bharat Biotech Genetically Engineered Vaccines Product Portfolios and Specifications
13.6.3 Bharat Biotech Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Bharat Biotech Main Business Overview
13.6.5 Bharat Biotech Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Genetically Engineered Vaccines Product Portfolios and Specifications
13.7.3 Sanofi Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 Zoties
13.8.1 Zoties Company Information
13.8.2 Zoties Genetically Engineered Vaccines Product Portfolios and Specifications
13.8.3 Zoties Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Zoties Main Business Overview
13.8.5 Zoties Latest Developments
13.9 Elanco
13.9.1 Elanco Company Information
13.9.2 Elanco Genetically Engineered Vaccines Product Portfolios and Specifications
13.9.3 Elanco Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Elanco Main Business Overview
13.9.5 Elanco Latest Developments
13.10 Boehringer Ingelheim
13.10.1 Boehringer Ingelheim Company Information
13.10.2 Boehringer Ingelheim Genetically Engineered Vaccines Product Portfolios and Specifications
13.10.3 Boehringer Ingelheim Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Boehringer Ingelheim Main Business Overview
13.10.5 Boehringer Ingelheim Latest Developments
13.11 Indian Immunologicals
13.11.1 Indian Immunologicals Company Information
13.11.2 Indian Immunologicals Genetically Engineered Vaccines Product Portfolios and Specifications
13.11.3 Indian Immunologicals Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Indian Immunologicals Main Business Overview
13.11.5 Indian Immunologicals Latest Developments
13.12 China Animal Husbandry Industry Co.,Ltd.
13.12.1 China Animal Husbandry Industry Co.,Ltd. Company Information
13.12.2 China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
13.12.3 China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 China Animal Husbandry Industry Co.,Ltd. Main Business Overview
13.12.5 China Animal Husbandry Industry Co.,Ltd. Latest Developments
13.13 Yebio Bioengineering Co., Ltd Of Qingdao
13.13.1 Yebio Bioengineering Co., Ltd Of Qingdao Company Information
13.13.2 Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Product Portfolios and Specifications
13.13.3 Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Yebio Bioengineering Co., Ltd Of Qingdao Main Business Overview
13.13.5 Yebio Bioengineering Co., Ltd Of Qingdao Latest Developments
13.14 Jinyu Bio-technology Co.,ltd.
13.14.1 Jinyu Bio-technology Co.,ltd. Company Information
13.14.2 Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
13.14.3 Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Jinyu Bio-technology Co.,ltd. Main Business Overview
13.14.5 Jinyu Bio-technology Co.,ltd. Latest Developments
13.15 HVRI
13.15.1 HVRI Company Information
13.15.2 HVRI Genetically Engineered Vaccines Product Portfolios and Specifications
13.15.3 HVRI Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 HVRI Main Business Overview
13.15.5 HVRI Latest Developments
13.16 Ringpu Biology
13.16.1 Ringpu Biology Company Information
13.16.2 Ringpu Biology Genetically Engineered Vaccines Product Portfolios and Specifications
13.16.3 Ringpu Biology Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Ringpu Biology Main Business Overview
13.16.5 Ringpu Biology Latest Developments
13.17 Kyoto Biken Laboratories
13.17.1 Kyoto Biken Laboratories Company Information
13.17.2 Kyoto Biken Laboratories Genetically Engineered Vaccines Product Portfolios and Specifications
13.17.3 Kyoto Biken Laboratories Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Kyoto Biken Laboratories Main Business Overview
13.17.5 Kyoto Biken Laboratories Latest Developments
13.18 FATRO
13.18.1 FATRO Company Information
13.18.2 FATRO Genetically Engineered Vaccines Product Portfolios and Specifications
13.18.3 FATRO Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 FATRO Main Business Overview
13.18.5 FATRO Latest Developments
13.19 Ceva Sant? Animale
13.19.1 Ceva Sant? Animale Company Information
13.19.2 Ceva Sant? Animale Genetically Engineered Vaccines Product Portfolios and Specifications
13.19.3 Ceva Sant? Animale Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Ceva Sant? Animale Main Business Overview
13.19.5 Ceva Sant? Animale Latest Developments
13.20 Pulike Biological Engineering,Inc.
13.20.1 Pulike Biological Engineering,Inc. Company Information
13.20.2 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Product Portfolios and Specifications
13.20.3 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Pulike Biological Engineering,Inc. Main Business Overview
13.20.5 Pulike Biological Engineering,Inc. Latest Developments
13.21 Wuhan Hvsen Biotechnology CO.,LTD
13.21.1 Wuhan Hvsen Biotechnology CO.,LTD Company Information
13.21.2 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Product Portfolios and Specifications
13.21.3 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Wuhan Hvsen Biotechnology CO.,LTD Main Business Overview
13.21.5 Wuhan Hvsen Biotechnology CO.,LTD Latest Developments
13.22 Jinhe Biotechnology Co., Ltd.
13.22.1 Jinhe Biotechnology Co., Ltd. Company Information
13.22.2 Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
13.22.3 Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Jinhe Biotechnology Co., Ltd. Main Business Overview
13.22.5 Jinhe Biotechnology Co., Ltd. Latest Developments
13.23 Shanghai Shen Lian Biomedical Corporation
13.23.1 Shanghai Shen Lian Biomedical Corporation Company Information
13.23.2 Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Product Portfolios and Specifications
13.23.3 Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Shanghai Shen Lian Biomedical Corporation Main Business Overview
13.23.5 Shanghai Shen Lian Biomedical Corporation Latest Developments
13.24 Qingdao Vland Biotech INC.
13.24.1 Qingdao Vland Biotech INC. Company Information
13.24.2 Qingdao Vland Biotech INC. Genetically Engineered Vaccines Product Portfolios and Specifications
13.24.3 Qingdao Vland Biotech INC. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Qingdao Vland Biotech INC. Main Business Overview
13.24.5 Qingdao Vland Biotech INC. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Genetically Engineered Vaccines Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Genetically Engineered Vaccines by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Genetically Engineered Vaccines by Country/Region, 2021, 2025 & 2032
2.2 Genetically Engineered Vaccines Segment by Type
2.2.1 Genetic Recombinant Vaccine
2.2.2 Recombinant Subunit Vaccines
2.2.3 Genetic Vaccine
2.2.4 Genetically Engineered Vaccines Sales by Type
2.2.4.1 Global Genetically Engineered Vaccines Sales Market Share by Type (2021-2026)
2.2.4.2 Global Genetically Engineered Vaccines Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Genetically Engineered Vaccines Sale Price by Type (2021-2026)
2.3 Genetically Engineered Vaccines Segment by Application
2.3.1 Veterinary Use
2.3.2 Human Use
2.3.3 Genetically Engineered Vaccines Sales by Application
2.3.3.1 Global Genetically Engineered Vaccines Sale Market Share by Application (2021-2026)
2.3.3.2 Global Genetically Engineered Vaccines Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Genetically Engineered Vaccines Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Genetically Engineered Vaccines Breakdown Data by Company
3.1.1 Global Genetically Engineered Vaccines Annual Sales by Company (2021-2026)
3.1.2 Global Genetically Engineered Vaccines Sales Market Share by Company (2021-2026)
3.2 Global Genetically Engineered Vaccines Annual Revenue by Company (2021-2026)
3.2.1 Global Genetically Engineered Vaccines Revenue by Company (2021-2026)
3.2.2 Global Genetically Engineered Vaccines Revenue Market Share by Company (2021-2026)
3.3 Global Genetically Engineered Vaccines Sale Price by Company
3.4 Key Manufacturers Genetically Engineered Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Genetically Engineered Vaccines Product Location Distribution
3.4.2 Players Genetically Engineered Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GENETICALLY ENGINEERED VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Genetically Engineered Vaccines Market Size by Geographic Region (2021-2026)
4.1.1 Global Genetically Engineered Vaccines Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Genetically Engineered Vaccines Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Genetically Engineered Vaccines Market Size by Country/Region (2021-2026)
4.2.1 Global Genetically Engineered Vaccines Annual Sales by Country/Region (2021-2026)
4.2.2 Global Genetically Engineered Vaccines Annual Revenue by Country/Region (2021-2026)
4.3 Americas Genetically Engineered Vaccines Sales Growth
4.4 APAC Genetically Engineered Vaccines Sales Growth
4.5 Europe Genetically Engineered Vaccines Sales Growth
4.6 Middle East & Africa Genetically Engineered Vaccines Sales Growth
5 AMERICAS
5.1 Americas Genetically Engineered Vaccines Sales by Country
5.1.1 Americas Genetically Engineered Vaccines Sales by Country (2021-2026)
5.1.2 Americas Genetically Engineered Vaccines Revenue by Country (2021-2026)
5.2 Americas Genetically Engineered Vaccines Sales by Type (2021-2026)
5.3 Americas Genetically Engineered Vaccines Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genetically Engineered Vaccines Sales by Region
6.1.1 APAC Genetically Engineered Vaccines Sales by Region (2021-2026)
6.1.2 APAC Genetically Engineered Vaccines Revenue by Region (2021-2026)
6.2 APAC Genetically Engineered Vaccines Sales by Type (2021-2026)
6.3 APAC Genetically Engineered Vaccines Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Genetically Engineered Vaccines by Country
7.1.1 Europe Genetically Engineered Vaccines Sales by Country (2021-2026)
7.1.2 Europe Genetically Engineered Vaccines Revenue by Country (2021-2026)
7.2 Europe Genetically Engineered Vaccines Sales by Type (2021-2026)
7.3 Europe Genetically Engineered Vaccines Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Genetically Engineered Vaccines by Country
8.1.1 Middle East & Africa Genetically Engineered Vaccines Sales by Country (2021-2026)
8.1.2 Middle East & Africa Genetically Engineered Vaccines Revenue by Country (2021-2026)
8.2 Middle East & Africa Genetically Engineered Vaccines Sales by Type (2021-2026)
8.3 Middle East & Africa Genetically Engineered Vaccines Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Genetically Engineered Vaccines
10.3 Manufacturing Process Analysis of Genetically Engineered Vaccines
10.4 Industry Chain Structure of Genetically Engineered Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Genetically Engineered Vaccines Distributors
11.3 Genetically Engineered Vaccines Customer
12 WORLD FORECAST REVIEW FOR GENETICALLY ENGINEERED VACCINES BY GEOGRAPHIC REGION
12.1 Global Genetically Engineered Vaccines Market Size Forecast by Region
12.1.1 Global Genetically Engineered Vaccines Forecast by Region (2027-2032)
12.1.2 Global Genetically Engineered Vaccines Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Genetically Engineered Vaccines Forecast by Type (2027-2032)
12.7 Global Genetically Engineered Vaccines Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Genetically Engineered Vaccines Product Portfolios and Specifications
13.1.3 Pfizer Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Genetically Engineered Vaccines Product Portfolios and Specifications
13.2.3 Merck Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Genetically Engineered Vaccines Product Portfolios and Specifications
13.3.3 GSK Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
13.4.1 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Company Information
13.4.2 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Product Portfolios and Specifications
13.4.3 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Main Business Overview
13.4.5 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Latest Developments
13.5 Walvax Biotechnology Co., Ltd.
13.5.1 Walvax Biotechnology Co., Ltd. Company Information
13.5.2 Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
13.5.3 Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Walvax Biotechnology Co., Ltd. Main Business Overview
13.5.5 Walvax Biotechnology Co., Ltd. Latest Developments
13.6 Bharat Biotech
13.6.1 Bharat Biotech Company Information
13.6.2 Bharat Biotech Genetically Engineered Vaccines Product Portfolios and Specifications
13.6.3 Bharat Biotech Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Bharat Biotech Main Business Overview
13.6.5 Bharat Biotech Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Genetically Engineered Vaccines Product Portfolios and Specifications
13.7.3 Sanofi Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 Zoties
13.8.1 Zoties Company Information
13.8.2 Zoties Genetically Engineered Vaccines Product Portfolios and Specifications
13.8.3 Zoties Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Zoties Main Business Overview
13.8.5 Zoties Latest Developments
13.9 Elanco
13.9.1 Elanco Company Information
13.9.2 Elanco Genetically Engineered Vaccines Product Portfolios and Specifications
13.9.3 Elanco Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Elanco Main Business Overview
13.9.5 Elanco Latest Developments
13.10 Boehringer Ingelheim
13.10.1 Boehringer Ingelheim Company Information
13.10.2 Boehringer Ingelheim Genetically Engineered Vaccines Product Portfolios and Specifications
13.10.3 Boehringer Ingelheim Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Boehringer Ingelheim Main Business Overview
13.10.5 Boehringer Ingelheim Latest Developments
13.11 Indian Immunologicals
13.11.1 Indian Immunologicals Company Information
13.11.2 Indian Immunologicals Genetically Engineered Vaccines Product Portfolios and Specifications
13.11.3 Indian Immunologicals Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Indian Immunologicals Main Business Overview
13.11.5 Indian Immunologicals Latest Developments
13.12 China Animal Husbandry Industry Co.,Ltd.
13.12.1 China Animal Husbandry Industry Co.,Ltd. Company Information
13.12.2 China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
13.12.3 China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 China Animal Husbandry Industry Co.,Ltd. Main Business Overview
13.12.5 China Animal Husbandry Industry Co.,Ltd. Latest Developments
13.13 Yebio Bioengineering Co., Ltd Of Qingdao
13.13.1 Yebio Bioengineering Co., Ltd Of Qingdao Company Information
13.13.2 Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Product Portfolios and Specifications
13.13.3 Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Yebio Bioengineering Co., Ltd Of Qingdao Main Business Overview
13.13.5 Yebio Bioengineering Co., Ltd Of Qingdao Latest Developments
13.14 Jinyu Bio-technology Co.,ltd.
13.14.1 Jinyu Bio-technology Co.,ltd. Company Information
13.14.2 Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
13.14.3 Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Jinyu Bio-technology Co.,ltd. Main Business Overview
13.14.5 Jinyu Bio-technology Co.,ltd. Latest Developments
13.15 HVRI
13.15.1 HVRI Company Information
13.15.2 HVRI Genetically Engineered Vaccines Product Portfolios and Specifications
13.15.3 HVRI Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 HVRI Main Business Overview
13.15.5 HVRI Latest Developments
13.16 Ringpu Biology
13.16.1 Ringpu Biology Company Information
13.16.2 Ringpu Biology Genetically Engineered Vaccines Product Portfolios and Specifications
13.16.3 Ringpu Biology Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Ringpu Biology Main Business Overview
13.16.5 Ringpu Biology Latest Developments
13.17 Kyoto Biken Laboratories
13.17.1 Kyoto Biken Laboratories Company Information
13.17.2 Kyoto Biken Laboratories Genetically Engineered Vaccines Product Portfolios and Specifications
13.17.3 Kyoto Biken Laboratories Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Kyoto Biken Laboratories Main Business Overview
13.17.5 Kyoto Biken Laboratories Latest Developments
13.18 FATRO
13.18.1 FATRO Company Information
13.18.2 FATRO Genetically Engineered Vaccines Product Portfolios and Specifications
13.18.3 FATRO Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 FATRO Main Business Overview
13.18.5 FATRO Latest Developments
13.19 Ceva Sant? Animale
13.19.1 Ceva Sant? Animale Company Information
13.19.2 Ceva Sant? Animale Genetically Engineered Vaccines Product Portfolios and Specifications
13.19.3 Ceva Sant? Animale Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Ceva Sant? Animale Main Business Overview
13.19.5 Ceva Sant? Animale Latest Developments
13.20 Pulike Biological Engineering,Inc.
13.20.1 Pulike Biological Engineering,Inc. Company Information
13.20.2 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Product Portfolios and Specifications
13.20.3 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Pulike Biological Engineering,Inc. Main Business Overview
13.20.5 Pulike Biological Engineering,Inc. Latest Developments
13.21 Wuhan Hvsen Biotechnology CO.,LTD
13.21.1 Wuhan Hvsen Biotechnology CO.,LTD Company Information
13.21.2 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Product Portfolios and Specifications
13.21.3 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Wuhan Hvsen Biotechnology CO.,LTD Main Business Overview
13.21.5 Wuhan Hvsen Biotechnology CO.,LTD Latest Developments
13.22 Jinhe Biotechnology Co., Ltd.
13.22.1 Jinhe Biotechnology Co., Ltd. Company Information
13.22.2 Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
13.22.3 Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Jinhe Biotechnology Co., Ltd. Main Business Overview
13.22.5 Jinhe Biotechnology Co., Ltd. Latest Developments
13.23 Shanghai Shen Lian Biomedical Corporation
13.23.1 Shanghai Shen Lian Biomedical Corporation Company Information
13.23.2 Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Product Portfolios and Specifications
13.23.3 Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Shanghai Shen Lian Biomedical Corporation Main Business Overview
13.23.5 Shanghai Shen Lian Biomedical Corporation Latest Developments
13.24 Qingdao Vland Biotech INC.
13.24.1 Qingdao Vland Biotech INC. Company Information
13.24.2 Qingdao Vland Biotech INC. Genetically Engineered Vaccines Product Portfolios and Specifications
13.24.3 Qingdao Vland Biotech INC. Genetically Engineered Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Qingdao Vland Biotech INC. Main Business Overview
13.24.5 Qingdao Vland Biotech INC. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Genetically Engineered Vaccines Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Genetically Engineered Vaccines Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Genetic Recombinant Vaccine
Table 4. Major Players of Recombinant Subunit Vaccines
Table 5. Major Players of Genetic Vaccine
Table 6. Global Genetically Engineered Vaccines Sales by Type (2021-2026) & (K Units)
Table 7. Global Genetically Engineered Vaccines Sales Market Share by Type (2021-2026)
Table 8. Global Genetically Engineered Vaccines Revenue by Type (2021-2026) & ($ million)
Table 9. Global Genetically Engineered Vaccines Revenue Market Share by Type (2021-2026)
Table 10. Global Genetically Engineered Vaccines Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Genetically Engineered Vaccines Sale by Application (2021-2026) & (K Units)
Table 12. Global Genetically Engineered Vaccines Sale Market Share by Application (2021-2026)
Table 13. Global Genetically Engineered Vaccines Revenue by Application (2021-2026) & ($ million)
Table 14. Global Genetically Engineered Vaccines Revenue Market Share by Application (2021-2026)
Table 15. Global Genetically Engineered Vaccines Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Genetically Engineered Vaccines Sales by Company (2021-2026) & (K Units)
Table 17. Global Genetically Engineered Vaccines Sales Market Share by Company (2021-2026)
Table 18. Global Genetically Engineered Vaccines Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Genetically Engineered Vaccines Revenue Market Share by Company (2021-2026)
Table 20. Global Genetically Engineered Vaccines Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Genetically Engineered Vaccines Producing Area Distribution and Sales Area
Table 22. Players Genetically Engineered Vaccines Products Offered
Table 23. Genetically Engineered Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Genetically Engineered Vaccines Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Genetically Engineered Vaccines Sales Market Share Geographic Region (2021-2026)
Table 28. Global Genetically Engineered Vaccines Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Genetically Engineered Vaccines Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Genetically Engineered Vaccines Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Genetically Engineered Vaccines Sales Market Share by Country/Region (2021-2026)
Table 32. Global Genetically Engineered Vaccines Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Genetically Engineered Vaccines Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Genetically Engineered Vaccines Sales by Country (2021-2026) & (K Units)
Table 35. Americas Genetically Engineered Vaccines Sales Market Share by Country (2021-2026)
Table 36. Americas Genetically Engineered Vaccines Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Genetically Engineered Vaccines Sales by Type (2021-2026) & (K Units)
Table 38. Americas Genetically Engineered Vaccines Sales by Application (2021-2026) & (K Units)
Table 39. APAC Genetically Engineered Vaccines Sales by Region (2021-2026) & (K Units)
Table 40. APAC Genetically Engineered Vaccines Sales Market Share by Region (2021-2026)
Table 41. APAC Genetically Engineered Vaccines Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Genetically Engineered Vaccines Sales by Type (2021-2026) & (K Units)
Table 43. APAC Genetically Engineered Vaccines Sales by Application (2021-2026) & (K Units)
Table 44. Europe Genetically Engineered Vaccines Sales by Country (2021-2026) & (K Units)
Table 45. Europe Genetically Engineered Vaccines Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Genetically Engineered Vaccines Sales by Type (2021-2026) & (K Units)
Table 47. Europe Genetically Engineered Vaccines Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Genetically Engineered Vaccines Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Genetically Engineered Vaccines Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Genetically Engineered Vaccines Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Genetically Engineered Vaccines Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Genetically Engineered Vaccines
Table 53. Key Market Challenges & Risks of Genetically Engineered Vaccines
Table 54. Key Industry Trends of Genetically Engineered Vaccines
Table 55. Genetically Engineered Vaccines Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Genetically Engineered Vaccines Distributors List
Table 58. Genetically Engineered Vaccines Customer List
Table 59. Global Genetically Engineered Vaccines Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Genetically Engineered Vaccines Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Genetically Engineered Vaccines Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Genetically Engineered Vaccines Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Genetically Engineered Vaccines Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Genetically Engineered Vaccines Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Genetically Engineered Vaccines Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Genetically Engineered Vaccines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Genetically Engineered Vaccines Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Genetically Engineered Vaccines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Genetically Engineered Vaccines Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Genetically Engineered Vaccines Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Genetically Engineered Vaccines Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Genetically Engineered Vaccines Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Pfizer Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 74. Pfizer Genetically Engineered Vaccines Product Portfolios and Specifications
Table 75. Pfizer Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Pfizer Main Business
Table 77. Pfizer Latest Developments
Table 78. Merck Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Genetically Engineered Vaccines Product Portfolios and Specifications
Table 80. Merck Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. GSK Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. GSK Genetically Engineered Vaccines Product Portfolios and Specifications
Table 85. GSK Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. GSK Main Business
Table 87. GSK Latest Developments
Table 88. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 90. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Main Business
Table 92. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Latest Developments
Table 93. Walvax Biotechnology Co., Ltd. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 95. Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Walvax Biotechnology Co., Ltd. Main Business
Table 97. Walvax Biotechnology Co., Ltd. Latest Developments
Table 98. Bharat Biotech Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Bharat Biotech Genetically Engineered Vaccines Product Portfolios and Specifications
Table 100. Bharat Biotech Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Bharat Biotech Main Business
Table 102. Bharat Biotech Latest Developments
Table 103. Sanofi Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Sanofi Genetically Engineered Vaccines Product Portfolios and Specifications
Table 105. Sanofi Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Sanofi Main Business
Table 107. Sanofi Latest Developments
Table 108. Zoties Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Zoties Genetically Engineered Vaccines Product Portfolios and Specifications
Table 110. Zoties Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Zoties Main Business
Table 112. Zoties Latest Developments
Table 113. Elanco Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Elanco Genetically Engineered Vaccines Product Portfolios and Specifications
Table 115. Elanco Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Elanco Main Business
Table 117. Elanco Latest Developments
Table 118. Boehringer Ingelheim Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Boehringer Ingelheim Genetically Engineered Vaccines Product Portfolios and Specifications
Table 120. Boehringer Ingelheim Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Boehringer Ingelheim Main Business
Table 122. Boehringer Ingelheim Latest Developments
Table 123. Indian Immunologicals Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. Indian Immunologicals Genetically Engineered Vaccines Product Portfolios and Specifications
Table 125. Indian Immunologicals Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Indian Immunologicals Main Business
Table 127. Indian Immunologicals Latest Developments
Table 128. China Animal Husbandry Industry Co.,Ltd. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 130. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. China Animal Husbandry Industry Co.,Ltd. Main Business
Table 132. China Animal Husbandry Industry Co.,Ltd. Latest Developments
Table 133. Yebio Bioengineering Co., Ltd Of Qingdao Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Product Portfolios and Specifications
Table 135. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Yebio Bioengineering Co., Ltd Of Qingdao Main Business
Table 137. Yebio Bioengineering Co., Ltd Of Qingdao Latest Developments
Table 138. Jinyu Bio-technology Co.,ltd. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 140. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Jinyu Bio-technology Co.,ltd. Main Business
Table 142. Jinyu Bio-technology Co.,ltd. Latest Developments
Table 143. HVRI Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. HVRI Genetically Engineered Vaccines Product Portfolios and Specifications
Table 145. HVRI Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. HVRI Main Business
Table 147. HVRI Latest Developments
Table 148. Ringpu Biology Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 149. Ringpu Biology Genetically Engineered Vaccines Product Portfolios and Specifications
Table 150. Ringpu Biology Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. Ringpu Biology Main Business
Table 152. Ringpu Biology Latest Developments
Table 153. Kyoto Biken Laboratories Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 154. Kyoto Biken Laboratories Genetically Engineered Vaccines Product Portfolios and Specifications
Table 155. Kyoto Biken Laboratories Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. Kyoto Biken Laboratories Main Business
Table 157. Kyoto Biken Laboratories Latest Developments
Table 158. FATRO Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 159. FATRO Genetically Engineered Vaccines Product Portfolios and Specifications
Table 160. FATRO Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 161. FATRO Main Business
Table 162. FATRO Latest Developments
Table 163. Ceva Sant? Animale Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 164. Ceva Sant? Animale Genetically Engineered Vaccines Product Portfolios and Specifications
Table 165. Ceva Sant? Animale Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 166. Ceva Sant? Animale Main Business
Table 167. Ceva Sant? Animale Latest Developments
Table 168. Pulike Biological Engineering,Inc. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 169. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 170. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 171. Pulike Biological Engineering,Inc. Main Business
Table 172. Pulike Biological Engineering,Inc. Latest Developments
Table 173. Wuhan Hvsen Biotechnology CO.,LTD Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 174. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Product Portfolios and Specifications
Table 175. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 176. Wuhan Hvsen Biotechnology CO.,LTD Main Business
Table 177. Wuhan Hvsen Biotechnology CO.,LTD Latest Developments
Table 178. Jinhe Biotechnology Co., Ltd. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 179. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 180. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 181. Jinhe Biotechnology Co., Ltd. Main Business
Table 182. Jinhe Biotechnology Co., Ltd. Latest Developments
Table 183. Shanghai Shen Lian Biomedical Corporation Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 184. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Product Portfolios and Specifications
Table 185. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 186. Shanghai Shen Lian Biomedical Corporation Main Business
Table 187. Shanghai Shen Lian Biomedical Corporation Latest Developments
Table 188. Qingdao Vland Biotech INC. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 189. Qingdao Vland Biotech INC. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 190. Qingdao Vland Biotech INC. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 191. Qingdao Vland Biotech INC. Main Business
Table 192. Qingdao Vland Biotech INC. Latest Developments
Table 1. Genetically Engineered Vaccines Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Genetically Engineered Vaccines Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Genetic Recombinant Vaccine
Table 4. Major Players of Recombinant Subunit Vaccines
Table 5. Major Players of Genetic Vaccine
Table 6. Global Genetically Engineered Vaccines Sales by Type (2021-2026) & (K Units)
Table 7. Global Genetically Engineered Vaccines Sales Market Share by Type (2021-2026)
Table 8. Global Genetically Engineered Vaccines Revenue by Type (2021-2026) & ($ million)
Table 9. Global Genetically Engineered Vaccines Revenue Market Share by Type (2021-2026)
Table 10. Global Genetically Engineered Vaccines Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Genetically Engineered Vaccines Sale by Application (2021-2026) & (K Units)
Table 12. Global Genetically Engineered Vaccines Sale Market Share by Application (2021-2026)
Table 13. Global Genetically Engineered Vaccines Revenue by Application (2021-2026) & ($ million)
Table 14. Global Genetically Engineered Vaccines Revenue Market Share by Application (2021-2026)
Table 15. Global Genetically Engineered Vaccines Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Genetically Engineered Vaccines Sales by Company (2021-2026) & (K Units)
Table 17. Global Genetically Engineered Vaccines Sales Market Share by Company (2021-2026)
Table 18. Global Genetically Engineered Vaccines Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Genetically Engineered Vaccines Revenue Market Share by Company (2021-2026)
Table 20. Global Genetically Engineered Vaccines Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Genetically Engineered Vaccines Producing Area Distribution and Sales Area
Table 22. Players Genetically Engineered Vaccines Products Offered
Table 23. Genetically Engineered Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Genetically Engineered Vaccines Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Genetically Engineered Vaccines Sales Market Share Geographic Region (2021-2026)
Table 28. Global Genetically Engineered Vaccines Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Genetically Engineered Vaccines Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Genetically Engineered Vaccines Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Genetically Engineered Vaccines Sales Market Share by Country/Region (2021-2026)
Table 32. Global Genetically Engineered Vaccines Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Genetically Engineered Vaccines Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Genetically Engineered Vaccines Sales by Country (2021-2026) & (K Units)
Table 35. Americas Genetically Engineered Vaccines Sales Market Share by Country (2021-2026)
Table 36. Americas Genetically Engineered Vaccines Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Genetically Engineered Vaccines Sales by Type (2021-2026) & (K Units)
Table 38. Americas Genetically Engineered Vaccines Sales by Application (2021-2026) & (K Units)
Table 39. APAC Genetically Engineered Vaccines Sales by Region (2021-2026) & (K Units)
Table 40. APAC Genetically Engineered Vaccines Sales Market Share by Region (2021-2026)
Table 41. APAC Genetically Engineered Vaccines Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Genetically Engineered Vaccines Sales by Type (2021-2026) & (K Units)
Table 43. APAC Genetically Engineered Vaccines Sales by Application (2021-2026) & (K Units)
Table 44. Europe Genetically Engineered Vaccines Sales by Country (2021-2026) & (K Units)
Table 45. Europe Genetically Engineered Vaccines Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Genetically Engineered Vaccines Sales by Type (2021-2026) & (K Units)
Table 47. Europe Genetically Engineered Vaccines Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Genetically Engineered Vaccines Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Genetically Engineered Vaccines Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Genetically Engineered Vaccines Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Genetically Engineered Vaccines Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Genetically Engineered Vaccines
Table 53. Key Market Challenges & Risks of Genetically Engineered Vaccines
Table 54. Key Industry Trends of Genetically Engineered Vaccines
Table 55. Genetically Engineered Vaccines Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Genetically Engineered Vaccines Distributors List
Table 58. Genetically Engineered Vaccines Customer List
Table 59. Global Genetically Engineered Vaccines Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Genetically Engineered Vaccines Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Genetically Engineered Vaccines Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Genetically Engineered Vaccines Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Genetically Engineered Vaccines Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Genetically Engineered Vaccines Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Genetically Engineered Vaccines Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Genetically Engineered Vaccines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Genetically Engineered Vaccines Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Genetically Engineered Vaccines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Genetically Engineered Vaccines Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Genetically Engineered Vaccines Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Genetically Engineered Vaccines Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Genetically Engineered Vaccines Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Pfizer Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 74. Pfizer Genetically Engineered Vaccines Product Portfolios and Specifications
Table 75. Pfizer Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Pfizer Main Business
Table 77. Pfizer Latest Developments
Table 78. Merck Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Genetically Engineered Vaccines Product Portfolios and Specifications
Table 80. Merck Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. GSK Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. GSK Genetically Engineered Vaccines Product Portfolios and Specifications
Table 85. GSK Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. GSK Main Business
Table 87. GSK Latest Developments
Table 88. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 90. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Main Business
Table 92. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Latest Developments
Table 93. Walvax Biotechnology Co., Ltd. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 95. Walvax Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Walvax Biotechnology Co., Ltd. Main Business
Table 97. Walvax Biotechnology Co., Ltd. Latest Developments
Table 98. Bharat Biotech Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Bharat Biotech Genetically Engineered Vaccines Product Portfolios and Specifications
Table 100. Bharat Biotech Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Bharat Biotech Main Business
Table 102. Bharat Biotech Latest Developments
Table 103. Sanofi Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Sanofi Genetically Engineered Vaccines Product Portfolios and Specifications
Table 105. Sanofi Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Sanofi Main Business
Table 107. Sanofi Latest Developments
Table 108. Zoties Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Zoties Genetically Engineered Vaccines Product Portfolios and Specifications
Table 110. Zoties Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Zoties Main Business
Table 112. Zoties Latest Developments
Table 113. Elanco Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Elanco Genetically Engineered Vaccines Product Portfolios and Specifications
Table 115. Elanco Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Elanco Main Business
Table 117. Elanco Latest Developments
Table 118. Boehringer Ingelheim Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Boehringer Ingelheim Genetically Engineered Vaccines Product Portfolios and Specifications
Table 120. Boehringer Ingelheim Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Boehringer Ingelheim Main Business
Table 122. Boehringer Ingelheim Latest Developments
Table 123. Indian Immunologicals Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. Indian Immunologicals Genetically Engineered Vaccines Product Portfolios and Specifications
Table 125. Indian Immunologicals Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Indian Immunologicals Main Business
Table 127. Indian Immunologicals Latest Developments
Table 128. China Animal Husbandry Industry Co.,Ltd. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 130. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. China Animal Husbandry Industry Co.,Ltd. Main Business
Table 132. China Animal Husbandry Industry Co.,Ltd. Latest Developments
Table 133. Yebio Bioengineering Co., Ltd Of Qingdao Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Product Portfolios and Specifications
Table 135. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Yebio Bioengineering Co., Ltd Of Qingdao Main Business
Table 137. Yebio Bioengineering Co., Ltd Of Qingdao Latest Developments
Table 138. Jinyu Bio-technology Co.,ltd. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 140. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Jinyu Bio-technology Co.,ltd. Main Business
Table 142. Jinyu Bio-technology Co.,ltd. Latest Developments
Table 143. HVRI Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. HVRI Genetically Engineered Vaccines Product Portfolios and Specifications
Table 145. HVRI Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. HVRI Main Business
Table 147. HVRI Latest Developments
Table 148. Ringpu Biology Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 149. Ringpu Biology Genetically Engineered Vaccines Product Portfolios and Specifications
Table 150. Ringpu Biology Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. Ringpu Biology Main Business
Table 152. Ringpu Biology Latest Developments
Table 153. Kyoto Biken Laboratories Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 154. Kyoto Biken Laboratories Genetically Engineered Vaccines Product Portfolios and Specifications
Table 155. Kyoto Biken Laboratories Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. Kyoto Biken Laboratories Main Business
Table 157. Kyoto Biken Laboratories Latest Developments
Table 158. FATRO Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 159. FATRO Genetically Engineered Vaccines Product Portfolios and Specifications
Table 160. FATRO Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 161. FATRO Main Business
Table 162. FATRO Latest Developments
Table 163. Ceva Sant? Animale Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 164. Ceva Sant? Animale Genetically Engineered Vaccines Product Portfolios and Specifications
Table 165. Ceva Sant? Animale Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 166. Ceva Sant? Animale Main Business
Table 167. Ceva Sant? Animale Latest Developments
Table 168. Pulike Biological Engineering,Inc. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 169. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 170. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 171. Pulike Biological Engineering,Inc. Main Business
Table 172. Pulike Biological Engineering,Inc. Latest Developments
Table 173. Wuhan Hvsen Biotechnology CO.,LTD Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 174. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Product Portfolios and Specifications
Table 175. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 176. Wuhan Hvsen Biotechnology CO.,LTD Main Business
Table 177. Wuhan Hvsen Biotechnology CO.,LTD Latest Developments
Table 178. Jinhe Biotechnology Co., Ltd. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 179. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 180. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 181. Jinhe Biotechnology Co., Ltd. Main Business
Table 182. Jinhe Biotechnology Co., Ltd. Latest Developments
Table 183. Shanghai Shen Lian Biomedical Corporation Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 184. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Product Portfolios and Specifications
Table 185. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 186. Shanghai Shen Lian Biomedical Corporation Main Business
Table 187. Shanghai Shen Lian Biomedical Corporation Latest Developments
Table 188. Qingdao Vland Biotech INC. Basic Information, Genetically Engineered Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 189. Qingdao Vland Biotech INC. Genetically Engineered Vaccines Product Portfolios and Specifications
Table 190. Qingdao Vland Biotech INC. Genetically Engineered Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 191. Qingdao Vland Biotech INC. Main Business
Table 192. Qingdao Vland Biotech INC. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Genetically Engineered Vaccines
Figure 2. Genetically Engineered Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Genetically Engineered Vaccines Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Genetically Engineered Vaccines Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Genetically Engineered Vaccines Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Genetically Engineered Vaccines Sales Market Share by Country/Region (2025)
Figure 10. Genetically Engineered Vaccines Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Genetic Recombinant Vaccine
Figure 12. Product Picture of Recombinant Subunit Vaccines
Figure 13. Product Picture of Genetic Vaccine
Figure 14. Global Genetically Engineered Vaccines Sales Market Share by Type in 2026
Figure 15. Global Genetically Engineered Vaccines Revenue Market Share by Type (2021-2026)
Figure 16. Genetically Engineered Vaccines Consumed in Veterinary Use
Figure 17. Global Genetically Engineered Vaccines Market: Veterinary Use (2021-2026) & (K Units)
Figure 18. Genetically Engineered Vaccines Consumed in Human Use
Figure 19. Global Genetically Engineered Vaccines Market: Human Use (2021-2026) & (K Units)
Figure 20. Global Genetically Engineered Vaccines Sale Market Share by Application (2025)
Figure 21. Global Genetically Engineered Vaccines Revenue Market Share by Application in 2026
Figure 22. Genetically Engineered Vaccines Sales by Company in 2026 (K Units)
Figure 23. Global Genetically Engineered Vaccines Sales Market Share by Company in 2026
Figure 24. Genetically Engineered Vaccines Revenue by Company in 2026 ($ millions)
Figure 25. Global Genetically Engineered Vaccines Revenue Market Share by Company in 2026
Figure 26. Global Genetically Engineered Vaccines Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Genetically Engineered Vaccines Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Genetically Engineered Vaccines Sales 2021-2026 (K Units)
Figure 29. Americas Genetically Engineered Vaccines Revenue 2021-2026 ($ millions)
Figure 30. APAC Genetically Engineered Vaccines Sales 2021-2026 (K Units)
Figure 31. APAC Genetically Engineered Vaccines Revenue 2021-2026 ($ millions)
Figure 32. Europe Genetically Engineered Vaccines Sales 2021-2026 (K Units)
Figure 33. Europe Genetically Engineered Vaccines Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Genetically Engineered Vaccines Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa Genetically Engineered Vaccines Revenue 2021-2026 ($ millions)
Figure 36. Americas Genetically Engineered Vaccines Sales Market Share by Country in 2026
Figure 37. Americas Genetically Engineered Vaccines Revenue Market Share by Country (2021-2026)
Figure 38. Americas Genetically Engineered Vaccines Sales Market Share by Type (2021-2026)
Figure 39. Americas Genetically Engineered Vaccines Sales Market Share by Application (2021-2026)
Figure 40. United States Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Genetically Engineered Vaccines Sales Market Share by Region in 2026
Figure 45. APAC Genetically Engineered Vaccines Revenue Market Share by Region (2021-2026)
Figure 46. APAC Genetically Engineered Vaccines Sales Market Share by Type (2021-2026)
Figure 47. APAC Genetically Engineered Vaccines Sales Market Share by Application (2021-2026)
Figure 48. China Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 52. India Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Genetically Engineered Vaccines Sales Market Share by Country in 2026
Figure 56. Europe Genetically Engineered Vaccines Revenue Market Share by Country (2021-2026)
Figure 57. Europe Genetically Engineered Vaccines Sales Market Share by Type (2021-2026)
Figure 58. Europe Genetically Engineered Vaccines Sales Market Share by Application (2021-2026)
Figure 59. Germany Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 60. France Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Genetically Engineered Vaccines Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Genetically Engineered Vaccines Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Genetically Engineered Vaccines Sales Market Share by Application (2021-2026)
Figure 67. Egypt Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Genetically Engineered Vaccines in 2026
Figure 73. Manufacturing Process Analysis of Genetically Engineered Vaccines
Figure 74. Industry Chain Structure of Genetically Engineered Vaccines
Figure 75. Channels of Distribution
Figure 76. Global Genetically Engineered Vaccines Sales Market Forecast by Region (2027-2032)
Figure 77. Global Genetically Engineered Vaccines Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Genetically Engineered Vaccines Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Genetically Engineered Vaccines Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Genetically Engineered Vaccines Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Genetically Engineered Vaccines Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Genetically Engineered Vaccines
Figure 2. Genetically Engineered Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Genetically Engineered Vaccines Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Genetically Engineered Vaccines Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Genetically Engineered Vaccines Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Genetically Engineered Vaccines Sales Market Share by Country/Region (2025)
Figure 10. Genetically Engineered Vaccines Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Genetic Recombinant Vaccine
Figure 12. Product Picture of Recombinant Subunit Vaccines
Figure 13. Product Picture of Genetic Vaccine
Figure 14. Global Genetically Engineered Vaccines Sales Market Share by Type in 2026
Figure 15. Global Genetically Engineered Vaccines Revenue Market Share by Type (2021-2026)
Figure 16. Genetically Engineered Vaccines Consumed in Veterinary Use
Figure 17. Global Genetically Engineered Vaccines Market: Veterinary Use (2021-2026) & (K Units)
Figure 18. Genetically Engineered Vaccines Consumed in Human Use
Figure 19. Global Genetically Engineered Vaccines Market: Human Use (2021-2026) & (K Units)
Figure 20. Global Genetically Engineered Vaccines Sale Market Share by Application (2025)
Figure 21. Global Genetically Engineered Vaccines Revenue Market Share by Application in 2026
Figure 22. Genetically Engineered Vaccines Sales by Company in 2026 (K Units)
Figure 23. Global Genetically Engineered Vaccines Sales Market Share by Company in 2026
Figure 24. Genetically Engineered Vaccines Revenue by Company in 2026 ($ millions)
Figure 25. Global Genetically Engineered Vaccines Revenue Market Share by Company in 2026
Figure 26. Global Genetically Engineered Vaccines Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Genetically Engineered Vaccines Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Genetically Engineered Vaccines Sales 2021-2026 (K Units)
Figure 29. Americas Genetically Engineered Vaccines Revenue 2021-2026 ($ millions)
Figure 30. APAC Genetically Engineered Vaccines Sales 2021-2026 (K Units)
Figure 31. APAC Genetically Engineered Vaccines Revenue 2021-2026 ($ millions)
Figure 32. Europe Genetically Engineered Vaccines Sales 2021-2026 (K Units)
Figure 33. Europe Genetically Engineered Vaccines Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Genetically Engineered Vaccines Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa Genetically Engineered Vaccines Revenue 2021-2026 ($ millions)
Figure 36. Americas Genetically Engineered Vaccines Sales Market Share by Country in 2026
Figure 37. Americas Genetically Engineered Vaccines Revenue Market Share by Country (2021-2026)
Figure 38. Americas Genetically Engineered Vaccines Sales Market Share by Type (2021-2026)
Figure 39. Americas Genetically Engineered Vaccines Sales Market Share by Application (2021-2026)
Figure 40. United States Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Genetically Engineered Vaccines Sales Market Share by Region in 2026
Figure 45. APAC Genetically Engineered Vaccines Revenue Market Share by Region (2021-2026)
Figure 46. APAC Genetically Engineered Vaccines Sales Market Share by Type (2021-2026)
Figure 47. APAC Genetically Engineered Vaccines Sales Market Share by Application (2021-2026)
Figure 48. China Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 52. India Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Genetically Engineered Vaccines Sales Market Share by Country in 2026
Figure 56. Europe Genetically Engineered Vaccines Revenue Market Share by Country (2021-2026)
Figure 57. Europe Genetically Engineered Vaccines Sales Market Share by Type (2021-2026)
Figure 58. Europe Genetically Engineered Vaccines Sales Market Share by Application (2021-2026)
Figure 59. Germany Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 60. France Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Genetically Engineered Vaccines Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Genetically Engineered Vaccines Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Genetically Engineered Vaccines Sales Market Share by Application (2021-2026)
Figure 67. Egypt Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Genetically Engineered Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Genetically Engineered Vaccines in 2026
Figure 73. Manufacturing Process Analysis of Genetically Engineered Vaccines
Figure 74. Industry Chain Structure of Genetically Engineered Vaccines
Figure 75. Channels of Distribution
Figure 76. Global Genetically Engineered Vaccines Sales Market Forecast by Region (2027-2032)
Figure 77. Global Genetically Engineered Vaccines Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Genetically Engineered Vaccines Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Genetically Engineered Vaccines Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Genetically Engineered Vaccines Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Genetically Engineered Vaccines Revenue Market Share Forecast by Application (2027-2032)
